SCHEMBL8006645

SCHEMBL8006645

Cc1nc2ccccc2nc1-c1ccco1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.75
MEN1 O00255 6/20 0.75
MAPT P10636 6/20 0.75
KMT2A Q03164 6/20 0.75
TDP1 Q9NUW8 5/20 0.75
KDM4E B2RXH2 5/20 0.75
POLB P06746 5/20 0.75
BLM P54132 5/20 0.75
RECQL P46063 4/20 0.75
HPGD P15428 4/20 0.75
L3MBTL1 Q9Y468 4/20 0.75
PTPN7 P35236 3/20 0.75
HSD17B10 Q99714 3/20 0.75
PKM P14618 2/20 0.75
ALOX15 P16050 2/20 0.75
CASP1 P29466 2/20 0.75
CASP7 P55210 2/20 0.75
TSHR P16473 2/20 0.75
THRB P10828 3/20 0.55
ALOX12 P18054 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27734202 0.86 MEN1 (1.00) ALDH1A1MEN1MAPTKMT2ATDP1
SCHEMBL13787415 0.79 ALDH1A1 (0.70) ALDH1A1MEN1MAPTKMT2ATDP1
SCHEMBL28079386 0.78 MEN1 (0.81) ALDH1A1MEN1MAPTKMT2ATDP1
SCHEMBL503307 0.78 MEN1 (0.75) ALDH1A1MEN1MAPTKMT2ATDP1
SCHEMBL28532446 0.77 TDP1 (0.62) ALDH1A1MEN1MAPTKMT2ATDP1
SCHEMBL20392752 0.75 ADORA2A (0.52) ALDH1A1MEN1MAPTKMT2ATDP1
SCHEMBL6238182 0.75 PIK3R1 (0.66) ALDH1A1MEN1MAPTKMT2ATDP1
SCHEMBL6238059 0.74 MAPT (0.62) ALDH1A1MEN1MAPTKMT2ATDP1
SCHEMBL7696747 0.73 TDP1 (1.00) ALDH1A1MEN1MAPTKMT2ATDP1
SCHEMBL3685471 0.73 ALDH1A1 (0.53) ALDH1A1MEN1MAPTKMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962551-B2 Quinoxalinyl derivatives ENANTA PHARMACEUTICALS, INC. (US) 2015-02-24 US disclosed
US-20090180981-A1 QUINOXALINYL DERIVATIVES ENANTA PHARMACEUTICALS, INC. 2009-07-16 US disclosed
WO-2009073719-A1 QUINOXALINYL DERIVATIVES ENANTA PHARMACEUTICALS, INC. (US) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090180981-A1 QUINOXALINYL DERIVATIVES SQOR, ATG4A, NQO1 ALDH1A1 746/4885MEN1 4281/4885MAPT 4629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.